New study shows that a Universal Medication Schedule could help diabetes patients.
According to PBMs, those drug coupons are something else.
PBMs have dodged state-mandated requirements for transparency in generics drug pricing, so many states are rewriting their laws.
Five years of imatinib treatment for CML = >$100,000 saved per patient.
Value-based care is transforming the world of healthcare. Simple cost management must give way to utilization management, and alignment of stakeholder services is inevitable.
Validation through inclusion in Medicare Part B could lead to recognition of pharmacists as healthcare providers across the board.